Competent Cells Companies

Latest Competent cells Companies Update

• 
  May 2023: The world's top supplier of services and instruments for life-science research, GenScript Biotech Corporation, has extended its main oligonucleotide and peptide production plant in Zhenjiang, Jiangsu, China. The addition strengthens GenScript's standing as a global provider of high-quality oligo and peptides for scientists, having done so over 20 years. The increased capacity for oligonucleotide synthesis provides qPCR, NGS, RNA, and DNA oligos, among other oligos, to facilitate a variety of uses, including genome editing, RNA interference, and molecular diagnostics. With large-scale, high-throughput synthesizers, rigorous cross-contamination control methods via HPLC+ and PAGE+ purification processes, and ISO 13485 certification, GenScript can meet a wide range of application needs by offering up to 200nt DNA and 180nt RNA oligonucleotides at up to 95% purity, from ug to kilogram level.

• 
  Nov 2023: Along with a partner at Juntendo University School of Medicine, Takara Bio Inc. has reported the discovery of a novel adeno-associated virus (AAV) vector, named Sonuaav, that shows excellent gene transfer efficiency into inner ear tissues.

• Thermo Fisher Scientific


• Merck KGaA


• Agilent Technologies, Inc.


• Takara Bio Inc.


• New England Biolabs (UK) Ltd.


• HiMedia Laboratories


• Zymo Research


• Avantor


• TransGen Biotech Co., Ltd


• Scarab Genomics


• Lucigen Corporation


• Genscript Corporation


• Tonbo Biosciences


• Enzynomics co Ltd


• Klee GmbH


• NZYTech, Lda